No local recurrence of enchondroma after curettage and plaster filling

Gaasbeek, Robert D.A.; Rijnberg, W. J.; Loon, C. J. M. van; Meyers, Harvey I.; Feith, R.

doi:10.1007/s00402-004-0747-5

Cited by 20 publications

(24 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…7,9,10,11 Purported advantages of these materials are immediate biomechanical stability to the tumor cavity, which can decrease the risk of postoperative fracture and provide a faster return to activity. Bickels et al used polymethylmethacrylate and K-wires within the tumor cavity of 13 patients without postoperative fractures or infections; however, 7 patients had decreased range of motion.…”

Section: Discussionmentioning

confidence: 99%

Enchondromas of the Hand: Factors Affecting Recurrence, Healing, Motion, and Malignant Transformation

Sassoon

Fitz‐Gibbon

Harmsen

et al. 2012

The Journal of Hand Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Enchondromas of the Hand: Factors Affecting Recurrence, Healing, Motion, and Malignant Transformation

Sassoon

Fitz‐Gibbon

Harmsen

et al. 2012

The Journal of Hand Surgery

View full text Add to dashboard Cite

“…There are several options for filling bone defects following curettage of enchondroma: autologous cancellous bone, bone graft substitutes [12][13][14] and curettage alone without augmentations [17][18][19]. Autologous bone grafting has been known as standard treatment option for filling bone defect following curettage.…”

Section: Discussionmentioning

confidence: 99%

“…The use of plaster of Paris or gypsum (calcium sulfate dehydrate/calcium phosphate) to fill the bone defects was first described by Dreesman in 1892 [11]. Since then, several clinical reports descriptions utilizing bone graft substitutes have been published [12][13][14][15]. However, few reports have commented on the clinical results of calcium sulfate pellet grafting in the treatment for enchondroma.…”

Section: Introductionmentioning

confidence: 99%

Treatment for hand enchondroma with curettage and calcium sulfate pellet (OsteoSet®) grafting

Choy

Kim

Lee

et al. 2011

Eur J Orthop Surg Traumatol

View full text Add to dashboard Cite

Enchondroma is the most common benign tumor that frequently occurs in hand. Curettage followed by augmentation of the void defect is the mainstay of enchondroma treatment such as autologous bone grafting or using bone graft substitutes. In this study, we analyzed the surgical results of a hand enchondroma treated by curettage and grafting with calcium sulfate pellet (OsteoSet Ò , Wright Medical Co, USA) grafting. Eighteen patients with hand enchondroma were reviewed. There were seven male cases and eleven female cases with the mean age of 35.4 years (range, 12-55). Involved bones were metacarpal (5 cases), proximal phalanx (7 cases), middle phalanx (3 cases) and distal phalanx (3 cases). The mean follow-up period was 32 months (range, 18-48). We analyzed the clinical result and radiologic appearance of the surgically treated digits. The resorption of calcium sulfate pellet and bone remodeling were checked by serial radiographs. The mean time for complete pellet resorption was postoperative 4 weeks (range, 3-6 weeks). Bone remodeling was completed in all cases at mean postoperative 10 weeks (range, 7-11). All surgically treated digits had full range of motion except one digit that was fixed with K-wire to treat a pathologic fracture simultaneously. No other complications and local recurrence were encountered. Curettage and calcium sulfate pellet (OsteoSet Ò ) grafting proved to be a safe, promising modality for treatment for hand enchondroma. It led to excellent functional and radiologic results.

show abstract

“…Recently, bone substitutes have also been used instead of autologous bone grafting. Although hydroxyapatite, beta-tricalcium phosphate, and various granular materials have excellent biocompatiblity, these can not be considered to provide sufficient structural strength before consolidation [1,6,12]. PMMA cement provides immediate mechanical stability [2], but the heat of polymerization and monomer toxicity are concerns.…”

Section: Discussionmentioning

confidence: 99%

Ollier's Disease Treated with Grafting Using Alpha-tricalcium Phosphate Cement. ACase Report

Sasaki

Hatori

Abe

et al. 2006

Upsala Journal of Medical Sciences

View full text Add to dashboard Cite

Ollier's disease is a rare disorder characterized by multiple enchondromas with a unilateral predominance, especially in fingers in early childhood. We experienced a case of Ollier's disease treated four times with simple curettage from the age of 2 years and alpha-tricalcium phosphate cement grafting at the age of 21 years. The forth curettage was performed when the patient was 15 years old and preoperative X-rays had shown remarkable finger deformities. Postoperative casting of the involved joints was necessary to prevent fractures but led to some finger contractures. Following X-rays demonstrated incredible improvement of the appearance. This suggests that simple curettage alone at an early stage of Ollier's disease provide cosmetic improvement.At the age of 21 years our patient showed enlargement of the intramedullary finger lesions again. Some lesions seemed to be impending pathological fractures. This time we chose alpha-tricalcium phosphate cement to fill the cavities after curettage had been carried out. Harvesting a large amount of autologous bone was not required. All activities of daily life could be resumed immediately after surgery and none of the finger joints showed further restriction of motion. X-rays taken three years after the operation showed new bone ingrowth surrounding the material with little evidence of absorption. To our knowledge, this may be the first case of Ollier's disease treated with artificial bone grafting reported in the English literature. 249

show abstract

No local recurrence of enchondroma after curettage and plaster filling

Abstract: Plaster of Paris appears safe and effective as a bone-filling substance after curettage of enchondroma.

Cited by 20 publications

References 14 publications

Enchondromas of the Hand: Factors Affecting Recurrence, Healing, Motion, and Malignant Transformation

Enchondromas of the Hand: Factors Affecting Recurrence, Healing, Motion, and Malignant Transformation

Treatment for hand enchondroma with curettage and calcium sulfate pellet (OsteoSet®) grafting

Ollier's Disease Treated with Grafting Using Alpha-tricalcium Phosphate Cement. ACase Report

Contact Info

Product

Resources

About